Kineta Inc. (NASDAQ: KA)
$0.73
-0.0020 ( -0.27% ) 87.3K
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.